The complete family of ApA phosphonate analogues with the internucleotide linkage elongated by insertion of a -CH2- group was prepared and the hybridisation and structural properties of its members in interaction with polyuridylic acid were investigated using an original 2D Raman approach. Except for the conformationally restricted A(CH)pA(2'3'endo-5') modification, all of the isopolar, non-isosteric analogues form triplex-like complexes with poly(rU) at room temperature, in which two polymer strands are bound by Watson-Crick and Hoogsteen bonds to a central pseudostrand consisting of a 'chain' of A-dimers. For all of these dimers, the overall conformation of the triplexes was found to be similar according to their extracted Raman spectra. A simple semi-empirical model was introduced to explain the observed dependency of the efficiency of triplex formation on the adenine concentration. Apparently, for most of the modifications studied, the creation of a stable complex at room temperature requires the formation of a central pseudostrand, consisting of several adenine dimers. Molecular dynamics calculations were finally performed to interpret the differences in 'cooperative' behaviour between the different dimers studied. The results indicate that the exceptional properties of the Ap(CH2)A(3'-5') dimer could be caused by the 3D conformational compatibility of this modified linkage with the second (Hoogsteen) poly(rU) strand.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC97576 | PMC |
http://dx.doi.org/10.1093/nar/29.24.5182 | DOI Listing |
Mol Ther Nucleic Acids
December 2024
Silence Therapeutics GmbH, Robert-Rössle-Street 10, 13125 Berlin, Germany.
Phosphorothioates (PSs) can be essential in stabilizing therapeutic oligonucleotides against enzymatic degradation. However, unless synthesis is performed with stereodefined amidites, each PS introduces a chemically undefined stereocenter, resulting in 2 unique molecules in the final product and affecting downstream analytics and purification. Replacing the second non-bridging oxygen with sulfur results in phosphorodithioate (PS2) linkages, thereby removing the stereocenter.
View Article and Find Full Text PDFChembiochem
November 2024
School of Chemistry and Trinity Biomedical Sciences Institute, Trinity College Dublin, the University of Dublin, Dublin 2, Ireland.
A series of chemically-modified oligonucleotides for targeting the DNA repair nuclease SNM1A have been designed and synthesised. Each oligonucleotide contains a modified internucleotide linkage designed to both mimic the native phosphodiester backbone and chelate to the catalytic zinc ion(s) in the SNM1A active site. Dinucleoside phosphoramidites containing urea, squaramide, sulfanylacetamide, and sulfinylacetamide linkages were prepared and employed successfully in solid-phase oligonucleotide synthesis.
View Article and Find Full Text PDFRSC Adv
October 2023
Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science 2641 Yamazaki, Noda Chiba 278-8510 Japan
We previously developed a synthesis method for oligodeoxynucleotides using -phosphonamidate derivatives as monomers. In this synthesis method, -phosphonamidate monomers having a heterocyclic amino group as a leaving group reacts with an alcohol to form an internucleotidic -phosphonate diester in pyridine without any additives upon heating. In this study, -phosphonamidate reacted to form an internucleotidic linkage in the presence of acidic activators at room temperature.
View Article and Find Full Text PDFExpert Opin Ther Pat
November 2023
Central International Intellectual Property (Baotou) Co. Ltd, Baotou, China.
Introduction: SiRNA molecules with a feature of good gene-silencing are critical for drug discovery and development based on RNA interference. GalNAc-RNA therapeutics is a rapid growing area in RNA therapeutics.
Areas Covered: This article provides patent landscape and modification feature of GalNAc-RNA therapeutics.
Trends Pharmacol Sci
December 2023
Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, Storrs, CT 06269, USA. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!